Bibliographic Details
| Title: |
UVA1 phototherapy as a treatment option for plaque psoriasis in HIV‐positive patients. |
| Authors: |
Arisi, Mariachiara1 (AUTHOR) mariachiara.arisi@gmail.com, Gelmetti, Alessandra1 (AUTHOR), Focà, Emanuele2 (AUTHOR), Rossi, Mariateresa1 (AUTHOR), Rovati, Chiara1 (AUTHOR), Calzavara‐Pinton, Piergiacomo1 (AUTHOR), Venturini, Marina1 (AUTHOR) |
| Source: |
Photodermatology, Photoimmunology & Photomedicine. Nov2020, Vol. 36 Issue 6, p478-480. 3p. |
| Subject Terms: |
*CHRONIC hepatitis B, *HIV-positive children, *HIGHLY active antiretroviral therapy, *PSORIASIS, *HIV |
| Abstract: |
As reported in Table 1, HIV RNA level after UVA1 phototherapy maintained stably below 50 copies/mL in patients 3 and 5 while decreased in patient 1 and 4 ( I P i > .05) according to the starting of antiretroviral therapy. Obviously, we must remember that any kind of phototherapy does not induce a systemic immunosuppression, and this put us far from considering UVA1 phototherapy as a treatment option for people living with HIV. In our small case series, UVA-1 phototherapy proved to be a safe and effective treatment option in psoriatic HIV-positive patients. [Extracted from the article] |
|
Copyright of Photodermatology, Photoimmunology & Photomedicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
